A Randomized, Double Blind, Placebo Controlled, Single Centric, 2 Arm Clinical Trial to Assess the Efficacy and Safety of Amrith Noni D Plus in Patients with Type II Diabetes Mellitus who are on OHA.

Abstract

The number of people with Diabetes Mellitus is rapidly increasing in the current generation. There are several medications researched and manufactured by the pharmaceutical industry but almost all of them have been reported to have some side effects or the other. Many researchers and doctors are trying to find natural alternatives that can keep the sugar levels under control. One such medicinally important plant is Morinda citrifolia L., commonly known as Noni. The primary objective of this study is to evaluate the efficacy of Amrith Noni D Plus in patients with Type II Diabetes Mellitus who are on Oral Hypoglycaemic Agent with that of a placebo. Apart from that the safety, tolerability of the same was also assessed. The study’s results show that there was no adverse effect after 24 weeks and there was a significant change in the laboratory tests conducted.